Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Phase 1

Completed

• Conditions: Spinal Cord Cancer; Brain (Nervous System) Cancers

• Registration Number: NCT00185666
• Lead Sponsor: Stanford University

Brief Summary

The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-05
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-16
• Primary Completion: 2006-05
• Study Completion: 2006-05
• Status Verified: 2010-07
• Last Update Submitted: 2010-07-12
• Last Update Posted: 2010-07-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Intra-axial, extra-axial, or vertebral spinal lesion

• Age > 5
• Histologic confirmation of malignant primary lesion or radiographic diagnosis of benign or vascular spinal lesion
• No rapidly deteriorating symptoms of spinal cord compression
• No instability of the spine
• Life expectancy > 6 months

Exclusion Criteria

• Patients without tumors of the spine

• Patients younger than 5 years old

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions	completed

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States